Search hospitals > North Carolina > Statesville
Wake Forest Baptist Health - Hematology Oncology - Statesville
Claim this profileStatesville, North Carolina 28677
Conducts research for Cancer
Conducts research for Skin Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Melanoma
12 reported clinical trials
5 medical researchers
Summary
Wake Forest Baptist Health - Hematology Oncology - Statesville is a medical facility located in Statesville, North Carolina. This center is recognized for care of Cancer, Skin Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Melanoma and other specialties. Wake Forest Baptist Health - Hematology Oncology - Statesville is involved with conducting 12 clinical trials across 26 conditions. There are 5 research doctors associated with this hospital, such as Jimmy Ruiz, Michael Goodman, MD, Michael K. Farris, and Pierre L. Triozzi.Area of expertise
1Cancer
Stage IV
Stage III
Stage I
2Skin Cancer
Stage IV
Stage III
BRAF positive
Top PIs
Jimmy RuizWake Forest University Health Sciences4 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
11 reported clinical trials
24 drugs studied
Michael Goodman, MDSalisbury W.G. (Bill) Hefner VA Medical Center, Salisbury, NC3 years of reported clinical research
Studies Prostate Cancer
Studies Cancer
7 reported clinical trials
18 drugs studied
Michael K. FarrisWake Forest University Health Sciences1 year of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
8 reported clinical trials
20 drugs studied
Pierre L. TriozziWake Forest University Health Sciences3 years of reported clinical research
Studies Skin Cancer
Studies Cutaneous Melanoma
5 reported clinical trials
9 drugs studied
Clinical Trials running at Wake Forest Baptist Health - Hematology Oncology - Statesville
Lung Cancer
Non-Small Cell Lung Cancer
Melanoma
Cutaneous Melanoma
Cancer
ALK Gene Rearrangement
Squamous Cell Carcinoma
Skin Cancer
Lung Carcinoma
Brain Metastasis
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting2 awards Phase 314 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Wake Forest Baptist Health - Hematology Oncology - Statesville?
Wake Forest Baptist Health - Hematology Oncology - Statesville is a medical facility located in Statesville, North Carolina. This center is recognized for care of Cancer, Skin Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Melanoma and other specialties. Wake Forest Baptist Health - Hematology Oncology - Statesville is involved with conducting 12 clinical trials across 26 conditions. There are 5 research doctors associated with this hospital, such as Jimmy Ruiz, Michael Goodman, MD, Michael K. Farris, and Pierre L. Triozzi.